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DELINEATION OF SEVERAL DR-RESTRICTED TETANUS TOXIN T CELL 
EPITOPES' 
STEPHANE DEMOTZ,'* ANTONIO  LANZAVECCHIA,+ ULRICH EISEL,*  HEINER NIEMANN,' 
CHRISTIAN WIDMANN,. AND GIAMPIETRO  CORRADIN3* 
We have  characterized  five  human T cell clones 
specific for tetanus  toxin. The  combination  of  dif- 
ferent  techniques  allowed us to precisely map  two 
T cell  epitopes  within  fragments 830-843 and  1273- 
1284 of tetanus  toxin, as formally  demonstrated  by 
the use of corresponding synthetic peptides. The 
three  other T cell clones were specific for regions 
2-602, 604-742, and 865-1315 of tetanus toxin, 
respectively. 
The  five T cell  clones were  shown to be  restricted 
to HLA-DR Ag. Furthermore,  the allele of HLA-DR 
utilized by the various epitopes has been deter- 
mined. The use of HLA-DR-transfected L cells as 
APC directly  demonstrated  that  two  epitopes,  one 
of  which  represented  by  fragment 1273-1284, were 
recognized in association with HLA-DRw52a. For 
the  other  three T cell epitopes,  the  data  strongly 
suggested  they  were  recognized  in  association  with 
Finally,  a sixth T cell  clone was  shown to be spe- 
cific for tetanus  toxoid,  the  vaccinal  preparation  of 
tetanus  toxin, and not for  other tetanus  toxin frag- 
ments.  This  indicated  that  immunization  with  teta- 
nus toxoid  probably elicits a T cell  response  directed 
only  in part against  native  tetanus  toxin. 
HLA-DR5. 
they could constitute  a peptide binding  site  (16,  17). A 
similar  three-dimensional model has been recently sug- 
gested for HLA class I1 molecules (1 8). 
To date, a limited number of human T cell epitopes 
have been characterized (5, 19, 20) and only in some 
cases have data concerning the utilization of the restric- 
tion  element  associated  with peptide been provided (20). 
Delineation of T cell epitopes and  their  restriction  pat- 
tern would be  useful not only for understanding the basis 
of recognition of Ag by class I1 molecules and TCR but 
also for designing synthetic vaccines. As recently dem- 
onstrated by several authors (21-25). it is possible to 
elicit neutralizing Ab4  by coupling B cell epitopes to T cell 
epitopes. 
The recent cloning and sequencing of the t.t. gene and 
the availability of recombinant  bacteria  expressing  frag- 
ments of t.t. of different  lengths  (26) combined with the 
fact  that almost all human beings are immunized against 
t.t.  make  this Ag an ideal choice for such  studies. 
Here  we report the epitope mapping of 6 Th cell clones 
as well as the determination of the type and allele of  MHC 
class I1 restriction Ag used. For two of these clones two 
synthetic  peptides of 12-1 4 amino acid residues  have 
proven to be stimulatory. 
MATERIALS AND METHODS 
It is now generally accepted that Th lymphocytes Cells and  mediafor cell culture. The  establishment of the  four 
ognize soluble protein Ag as processed proteolytic frag- EBV-transformed B  cell lines  4.2,  11.3.8.5,  and  KK.35  was  previ- 
merits in association with MHC class 11 molecules on the ously  described  (27).  These cell lines  were  maintained  in  culture  for 
the  past 2 yr. RPMI medium (GIBCO, Paisley.  Scotland)  supplemented 
generated  indicating that in the  murine  and fn the  human pyruvate, 5 x M 2-ME. and 1% of a 1OOx mixture of nonessen- 
surface Of APC (1-3). In recent years* data have been with 10% heat-inactivated FCS, 2 mM L-glutamine, 1 mM sodium 
- - systems a limited number of epitopes within a single Gal amino acids (GIBCO. Paisley, Scotland) was used (RPMI-c). 
protein are recognized by in the context Of a sing1e 40, and KT-42 were derived from a single DR3,5+ donor. These T 
The  autologous CD4+ T  cell clones KT-1,  KT-2, KT-4,  KT-30, KT- 
MHC class I1 restriction  element (4- 13).  The basis of these cell clones  were  established as described 1271 and  were  continuouslv 
findings  has been attributed t i  the specific  binding of maintained in culture by periodic restimulaiion by using irradiated 
these peptides to the proper restriction (14* 15)' the T cell blasts  were  xtensively  washed  and  cultured  in RPMI-c 
PBMC and 1% PHA. M form (GIBCO. Long Island, NY). After 5 days, 
Recently, the  structure of the HLA-A2 molecule was pro- supplemented  with  40 U/ml  of human r1L-2. 
vided and  supports  this concept. Portions of the outer Ag preparations and chernlcals. t.t.. B-fr. and C-fr  were  obtained 
extracellular domains of the  chain are arranged so that from  Calbiochem,  La  Jolla, CA. TT was a gift of Dr. J. Cryz. Swiss Serum  Institute.  Bern,  Switzerland.  Protein  concentration of these 
preparations  was  determined  by  using a Bio-Rad protein  assay (Bio- 
Received for publication June IO.  1988. Rad  Laboratories,  Munchen.  West  Germany). A schematic  represen- 
Accepted for publication October 21,  1988. tation of t.t.  and  derived  peptides is presented  in  Figure 1. 
The costs of publication of this article were defrayed in part by the Reduction was performed in PBS (pH 7.0) and by using 
payment of page charges. This article must therefore be hereby marked 20 mM dithiothreitol  for 30 min  at  37°C. T h e   ~ ~ d u c e d  Proteins  were 
adoertisernent in accordance with 18 u.S.C. Section 1734 solely to indi- carboxymethylated  with 80 mM iodoacetamide  for 60 min at 4°C in 
cate  this  fact. the  dark.  The  material  was  then  extensively  dialyzed  against  water. 
Foundation Grant 3.386-0.86 and  an EN1 Grant. 
' Part of this research was supported by the Swiss National Science Cyanogen bromide treatment was performed as described (28). 
250. San Diego. CA 92  130. 
'Present address: Cytel Corporation. 12520 High Bluff Drive, Suite Abbreviations used in this paper: Ab, antibody; t.t.. tetanus toxin: B- 
fr.  tetanus toxin B-fragment: C-fr. tetanus toxin C-fragment: RCM-t.t.. 
radin. lnstitut de Biochimie. UniversitC de  Lausanne. Chemin des Bover- bromide-treated RCM4.t.: chym. RCM-C-fr. chymotrypsin-treated RCM- 
"Correspondence and reprint  requests  should be addressed  to G. Cor- reduced and carboxymethylated tetanus toxin; CNBr RCM4.t.. cyanogen 
esses. 1066 Epalinges,  Switzerland. C-fr: chym. RCM4.t.. chymotrypsin-treated RCM-t.t.: TT. tetanus toxoid. 
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Floure 1 .  Schematic remesentation of tetanus toxin. The regions corresponding to the H and L chains, B-fr and C-fr as well as recombinant " Y 
fragments tet3  and tetl5  are shown. 
Briefly, lyophilized protein samples were redissolved in 70% formic 
acid and cyanogen bromide freshly dissolved a t  0.1  to 1  mgjml in 
acetonitrile  was added to a methionine residue  molar ratio of 100  to 
1. After 24 h incubation a t  room temperature in the dark, the 
samples were lyophilized and redissolved in  20 mM NaOH. 
Chymotrypsin treatment  was performed in PBS (pH 7.0)  for  24 h 
at  37°C by using a weight to weight ratio of enzyme to  substrate of 
1 to  20  (chymotrypsin,  type 11. Sigma,  St Louis, MO). RCM-t.t. at 2 
mgml  in HzO was buffered with 10-fold concentrated PBS and 
chymotrypsin  was added to a final  concentration of 50 pgjml. Six 
hours  later, a similar  amount of chymotrypsin  was added and  incu- 
bated  for  further  18  h. 
residues)  treatment was performed in HBSS (GIBCO. Paisley, Scot- 
Trypsin (cleavage at  the N-terminal side of lysine and  arginine 
land)  for  24 h at  37°C (trypsin,  type XIII, Sigma, St Louis, MO).  CNBr 
RCM-t.t. a t  2  mgjml in  20 mM  NaOH was buffered  with concentrated 
HBSS and  trypsin  was added to a final  concentration of 50 pg/ml. 
Six hours  later, a similar  amount of trypsin  was added and  incubated 
for a further  18  h. 
V8 protease treatment (clevage at   the N-terminal  side of glutamic 
acid residues at  pH 4.0  in  ammonium  acetate  buffer  and cleavage a t  
the N-terminal  side of glutamic  acid and  aspartic acid residues at  pH 
7.8 in  phosphate  buffer)  (29)  was performed either  in  acetate  buffer 
in phosphate buffer (100 mM NaH,P04, adjusted at  pH 7.8 with 
(100 mM ammonium  acetate, adjusted at  pH 4.5  with acetic  acid) or 
NaOH). The digestion was performed as described  for trypsin  (Staph- 
IN). 
ylococcus aureus V8 endoproteinase. Miles Laboratories, Elkhart, 
of lysine residues) was performed in phosphate buffer (100 mM 
Lys-C endoproteinase  treatment (cleavage at  the C-terminal  side 
NaH,PO,, pH 8.2) as described for trypsin (Lys-C endoproteinase 
from  Lysobacter  enzymogenes, Calbiochem, La Jolla, CA). 
Asp-N endoproteinase of Pseudomonas fragi mutant was ob- 
tained from  Boehringer, Mannheim. West Germany. Digestion 
(cleavage at  the N-terminal side of aspartic acid and cysteic acid 
residues)  was performed in  100 mM NaH2P04 (pH 8.2) for 24 h at  
37°C by using a ratio of enzyme to  substrate of 1 to  50. CNBr  RCM- 
t.t. a t  2 mgjml  in 20 mM  NaOH was buffered with 1 M NaH2P04, pH 
8.2. Fifty micrograms of  CNBr RCM4.t. peptides were added to 2 pg 
of lyophilized enzyme. The digestion was performed at  37°C for  24 
h. 
Performic  acid was prepared as described (30). Briefly, 950 pl of 
98 to  100% formic  acid  were mixed with 50 11130% H202 and kept  2 
h  on ice in a sealed  Eppendorf tube.  Then,  10 pl of performic  acid 
(oxidization of tyrosine  and  tryptophane residues)  were  added to 500 
pg CNBr RCM-t.t. a t  2 mgml  and  the pH was adjusted to 1 with  10 
pl of 37% HC1. After 2  h incubation  on ice, the  sample  was lyophi- 
lized. 
Lysates of Escherichia coli transfected with pUC12 derived plas- 
mids coding for  fragments of the  t.t.  gene were  obtained as follows. 
A single colony was grown  overnight a t  room temperature  in  20 ml 
LB medium (31). Two milliliters of bacteria  culture were transferred 
in  20 ml of fresh LB medium and grown  for  1  h at 37°C. Exponen- 
tially growing cultures were then induced for 2 h. Tet l5  (t.t.  fragment 
604-1315)  under control of the Trp-Lac fusion promoter was  in- 
duced by adding 1 mM isopropyl (3-o-thiogalactopyranoside (Sigma, 
St Louis. MO). Tet3  (t.t.  fragment  744-1315) which is controlled by 
the tsCI repressor was shifted at  42°C (26). Bacteria were sedi- 
mented.  resuspended  in 2 ml of 30 mM Tris.  20%  sucrose,  and  10 
mM EDTA (pH 8.0)  and were treated with 500 pgjml lysozyme for 
30 min at  37°C. Then,  the cells  were  sedimented. resuspended  in 2 
ml bidistilled H20,  and sonicated (three  times  for  20 s .  Sonifier B- 
12.  Branson Sonic Power Company. Danbury. CT). Fusion proteins 
were collected by 50% saturated ammonium sulfate precipitation 
followed  by centrifugation (10.000 X g. 30 min, 4 T ) .  The pellet was 
resuspended in PBS and dialyzed against the same buffer. RCM- 
tetl5  was prepared as described for RCM-t.t. 
procedure  described by Greenwood et al. (32). "'I-NaI (600 MBq/pg 
Immunoprecipitation.  t.t.  was labeled with lZ5I according to  the 
iodine) was supplied by Amersham International.  Amersham, UK. 
Usually, sp.  act.  was  5000  cpm/ng protein.  One hundred microliters 
of B cell culture  supernatant or RPMI-c were mixed with 5 $1 of lZ5l- 
t.t.  in  the presence or absence of 5 pl of cold competitor (t.t., B-fr, or 
C-fr)  added in 100-fold molar  excess relatively to labeled t.t. After 
a n  incubation of 60 min at room temperature,  20 pl of protein A- 
Sepharose  (Pharmacia, Uppsala,  Sweden) were added for a n  addi- 
tional 30-min  incubation.  Then,  the  beads were washed three  times 
with  500 pl  PBS. Beads and pooled supernatants were counted. 
ELISA. Aliquots of 100 pl of Ag (5 pgjml t.t. or tet3.  tetl5,  and 
RCM-tet15 lysates diluted 100-fold in PES) were coated overnight at 
4°C in wells of 96-well polyvinylchloride plates (Dynatech  Labora- 
tories  Inc.,  Alexandria, VA). The wells were then washed three  times 
with  200 pl PBS/O.2% BSA and  100 pl  of B cell culture  supernatant 
were incubated for 60 min at  room temperature. The wells were 
antibodies  anti-human IgG (Sigma, St Louis, MO) in PBS/O.2% BSA 
then washed a s  previously and  100 pl of a  1000-fold dilution of goat 
were incubated for 60 min. After three repetitive washings,  100 pl 
of a 1 mgjml  solution of p-nitrophenyl  phosphate in 1 M diethanol- 
amine  and 1 mM MgC1, (pH 9.8) were  added. Ten  to 60 min later, 
absorbance  was  measured at  405  nm. 
Th lymphocyte  proliferation  assay. One hundred microliters of 
Ag in RPMI-c were  distributed  in the wells of 96-(flat or round  bottom) 
well plates (Costar, Cambridge, MA, or Nunc, Roskilde, Denmark, 
respectively).  B  cells were washed twice. resuspended in RPMI-c and 
2. lo4 fixed (round bottom wells) or live (flat bottom wells) and 
irradiated  B  cells (3500  rad) were seeded in 50 pl/well. B cells were 
fixed as described previously (33). Briefly, B cells were washed  once 
in HBSS and fixed with 0.05% glutaraldehyde for 0.5 min. The 
reaction was stopped by adding RPMI. The cells were then  centri- 
fuged and washed three times. 
T  cells  rested  for a t  least 1 wk in rIL-2 containing RPMI-c were 
washed twice in RPMI and resuspended  in RPMI-c. Two X 1 O4 T cells 
in 50 p1 were distributed in the wells. After 48 h incubation  at 37°C 
in 5% CO,. 1 pCi of [meth~l-~HIthymidine (185 GBq/mmol. Amer- 
sham  International.  Amersham. UK) in  10 pl was added. After 20 h 
pulse, cell-incorporated radioactivity was determined. 
It was observed that T  cells  may  proliferate  upon  addition f  CNBr 
RCM-t.t. and in the  absence of B  cells.  Therefore, in order to  establish 
the MHC restriction, homozygous B cell lines EDR (DRl.1). COX 
(DR3.3). HAR (DR3.3). WT 20 (DR3,3). WT 49 (DR3,3), LG 14 (DR3.3). 
ATH (DR5,5),  and LG 38 (DR5.5) were pulsed overnight with 40 pg/ 
ml CNBr RCM-t.t., washed three  times  and  2. lo4 irradiated  B  cells 
were  tested  with 2. lo4 T  cells. 
81.19)  and DRw52b (TR-163) were used as APC. The establishment 
Murine L cells transfected with DR3 (TR-166-C2), DRw52a (TR- 
and characterization of these cell lines were described elsewhere 
(34). After overnight pulsing with 100 pgjml CNBr RCM-t.t., cells 
were fixed as described previously and  2. lo4 L cells/well were used 
in the proliferation assay. 
Inhibition of Th lymphocyte proliferation by using anti-MHC 
class I 1  Ag mAB. KK.35 B cells were pulsed overnight in RPMI-c 
containing  0.25 pg/ml t.t.  and  then glutaraldehyde fixed and washed 
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as described.  Inhibition of T cell proliferation by anti-MHC class I1 
Ag mAb was observed only with a limiting number of t.t. pulsed and 
fixed B  cells; 5.10' to 5 .  lo3 fixed B  cells were added to  2. lo4 T  cells 
to a 100 pl final volume of RPMI-c. mAb L-243 (anti-DR mAb. 
American Tissue Collection, Rockville. MD) (35). B-7.21 (anti-DP 
mAb. Dr. R. Accolla. Ludwig Institute, Epalinges.  Switzerland) (36, 
37) and Leu-10 (anti-DQ mAb, Becton Dickinson, Munchenstein, 
Switzerland)  were  used at  a final  concentration of 8 pg protein/ml. 
Chym. RCM-C-fr was  chromatographed on a Vydac 10 C-18 reverse 
Purtfication,  amino  acid analyses  and synthes is  of pept ides .  
phase column (HPLC technology Ltd., Palos Verdes Peninsular, CA) 
by using a Waters Associates System (Milford. MA). Elutlon was 
performed by forming a linear  gradient of 0% to  30% acetonitrile 
(Romil Chemicals. Shepshed Leics, England)  and  either  25 mM am- 
monium acetate (pH 6.0) or 0.05% trifluoroacetic  acid. Usually the 
gradient  was completed in 60 min  at a flow rate of 1 ml/min.  One 
milliliter fractions were collected, lyophilized, and  resuspended in 
water  and  subsequently tested in a T cell proliferation assay. 
Peptides  were hydrolyzed in 6 N HCl under  vacuum  and  the  amino 
acid composition was determined by the dabsyl  chloride  method (38). 
Peptides were sequenced on an automated sequencer (Applied 
dative  method (39). 
Biosystems. Foster City. CA) by using  the  sequential  Edman degra- 
Synthetic peptides  were obtained by solid phase  synthesis accord- 
ing to  the method of Merrifield modified by Atherton et al. (40) by 
using F-MOC protected amino  acids (Bachem. Bubendorf. Switzer- 
land). 
Peptides were sequentially  purified by gel filtration on a Sephadex 
G-10 (Pharmacia AB. Uppsala, Sweden) column and  then reverse 
phase HPLC by using a C- 18  column as described above. 
RESULTS 
Characterization of t.t.-specgic B cell lines. To take 
full advantage of the high presenting capacity of Ag- 
specific B  cells, we have  characterized the binding  spec- 
ificity of the Ab they produced. 
Radioiodinated t.t. was immunoprecipitated with Ab 
secreted by the various  B cell lines in the presence or 
absence of an excess of either  t.t., B-fr. or C-fr. In the 
presence of 100-fold molar  excess of cold t.t. relatively to 
labeled t.t.,  the binding was completely abrogated (Table 
I). When B-fr was used as competitor, lZ5I-t.t. binding by 
8.5, 1  1 .3, and KK. 35 Ab was not reduced whereas 1251- 
t.t. binding by 4.2 Ab was reduced by 80%. On the  other 
hand, unlabeled C-fr added in  excess  inhibited  binding 
of l*"I-t.t. by 8.5, 11.3,  and KK.35  Ab, whereas it did 
not affect  binding of 4.2 Ab (Table I). Taken  together, 
these  data indicated that 8.5, 1 1 a 3  and K K . 3 5  Ab bound 
determinants located on  the C-fr whereas 4.2 Ab was 
specific for the B-fr. 
An  ELISA was used to assess  that  the C-fr containing 
recombinant fragments  744- 13  15 (tet3)  and  604- 13 15 
(tet  15) were detected by  Ab produced by the t.t.-specific 
B cells (Fig. 1). The  8.5, 11 -3, and KK. 35 Ab detected 
TABLE I 
Bindlng of t.t.. Brfr. and Crfr by Ab produced by t.t.-specific B cell 
lines 
6 Cell Culture 
Supernatant" 
1251-t.t.. cpm x hound (9% inhihill~n]~. with 
Cold  Ag Competitor: 
None t.t .  6-fr C-fr 
8.5 
11.3 
10.3 1.2  (87) 9.3 (6) 0.9 (89) 
8.5 0.5 (95) 8.3 (2) 1.5 (83) 
KK.35 9.0 0.5 (95) 8.7 (0) 0.8 (91) 
4.2  6.3 0.8187) 1.1 ( S O )  6.2 (0) 
Medium 0.3 
"Five microliters of 12?-t.t. were added to 100 p1 of B cell culture 
supernatant or medium  in the presence or absence of unlabeled t.t.. B-fr. 
or C-fr added  100-fold  in  molar excess relative  to  '251-t.t.  After 60 min. 
20 p1 of protein  A-Sepharose  were  added for 30 min. 
of triplicates. SD  were less than 10%. Percentage of inhibition due  to the 
*Washed beads and  supernatants were counted. Results are the mean 
presence of cold  Ag competitor is indicated in parentheses. 
tet3  and  tet  15 fusion  proteins  when adsorbed on a  plastic 
solid-phase, whereas the B-fr-specific 4.2 Ab did not 
detect  them (Table 11, Expt.  1). RCM-tet15 was no more 
bound by 8.5 and 1  1 e 3 Ab (Table 11, Expt. 2).  These  data 
indicated that  tet3  and  tet  15  t.t. recombinant  fragments 
were recognized  by the  three C-fr-specific Ab and  that 
the binding of these Ab was  dependent on the confor- 
mation of the  determinants they recognized. 
Mapping of T cetl epitopes  by using proteolytic or 
recombinant fragments of t.t. Different t.t.  preparations 
(Fig. 1) were tested for their ability to trigger the prolif- 
erative  response of six  human T cell clones. 
Out of six T cell clones examined,  three of them were 
specific for the B-fr and two others for the C-fr (Table 111, 
Expt. 1).  The clone KT-1 was not stimulated to proliferate 
upon challenge with either t.t., B-fr, or C-fr. However, 
this clone was specific for T T ,  indicating that it recog- 
nized either an epitope specific for TT or a clostridial 
protein found in TT preparations (Table 111, Expt. 1). Two 
recombinant  fragments of t.t. were used to further define 
the location of the epitopes recognized  by the T cell clones 
(26).  Tet3  and tetl5 were recognized  by the Ab secreted 
by the C-fr-specific B cell lines 8.5, 11.3,  and K K . 3 5  
(Table 11). Tet3 covers the region 744- 13 15 and  tet 15 the 
region 604-1315 of t.t. (Fig. 1). As  expected, KT-4 and 
KT-30 T cells which are specific for the C-fr recognized 
tet3  and  tet  15 fusion  proteins  presented by KK .35 B cells 
(Table 111, Expt. 2). 
KT-2 cells recognized tet3  and  tet 15, KT-42 only tet 1 5 
and KT-40 none of them (Table 111, Expt. 2). Therefore, 
KT-2 recognized an  epitope located on the overlapping 
fragment between the B-fr and  tet3 which is the peptide 
744-864. KT-42 was specific for the  fragment  604-743, 
representing  the N-terminal region of tetl5 which does 
not overlap with tet3. KT-40 recognized an epitope lo- 
cated  on the  fragment 2-602. 
The effect of Ag specificity of the B cells on their 
presenting capacity was analyzed. Proliferation of the 
KT-2 T cell clone was measured in response to t.t.  and B- 
fr presented by either the B-fr-specific B cell line 4 - 2  or 
the C-fr-specific B cell line KK.35.  Whatever was the 
presenting cell, KT-2 T cell proliferation triggered by t.t. 
was  similar (Fig. 2). In contrast. 4.2 B cells stimulated 
KT-2 T cells with 8-fr at a 1 00-fold  lower concentration 
TABLE 11 
Irnrnunodetection of t .t .  recornblnantfragrnents tet3 and tetl.5 by 
C-fr-specific Ab 
6 Cell Culture 
Supernatanla 
Absorbance at 405 nmb 










0.75 0.50 0.57 ND 
0.76 0.47 0.53 ND 
0.80 0.18 0.19 ND 
0.09 0.19 0.17 ND 
1.46 1.35 1.41 0.37 
1.62 1.27 1.44 0.31 
0.12 0.18 0.27 0.30 
incubated for 60 min and washed as previously.  One hundred microliters 
a One hundred microliters of B cell culture supernatant or RPMI-c  were 
of a 1000-fold  dilution  of  goat Ab anti-human IgG coupled to alkaline 
phosphatase were incubated for 30 min and then washed three times. 
measured at 405 nm after IO to 60 min. The results are  the mean of 
bAbsorbance of a 1 mg/ml solution of p-nitrophenyl phosphate was 
quadriplicate wells. SD  were less than 10%. 
Wells  were coated  overnight at 4°C  with t.t.  (5  pgml). tet3, tetl5 and 
RCM-tet15 (lysate dilutlon 1/100 in PBS) and then washed (3 X 200 p l  
I'BS/O.Z%  BSA). 
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TABLE 111 
ProliJeratiue  response of TT-spec f i c  T cell  clones  to  uarious t.  t. preparations 
AR" 
[3H]Thyrnidlnc. cpm x lo-=. Incorporatedb 
KT- 1 KT-2 KT-4 KT-30  KT-40 KT-42 
Expt. 1 
TT 19.4'2.1 31.05 4.5 44.5% 1.2 27.4 f 3.2 45.6 f 7.2 45.7 % 2.9 
t.t 7.7 f0.3 48.1 5 5.3 51.72  5.3 55.5 f 3.3 105.1 2 3 . 4  49.8f3.2 
8-fr 7.3 f 0.3 23.2 2 4.8 4 .2  * 0.1 3.9 5 0.7 99.2 f 4.9 43.3 2 5.2 
C-fr 4 .3  c 0.2 2.8 f 0.2 48.0 5 7.1 68.2 2 4.5 9.1 f 1.2 6.0 f 0 . 4  
None 7 . 2  f 0.4 2.0 * 0.1 4.1 ? 0 . 3  3.0 -t 0.1 5.5 * 1.1 6.2 f 1.2 
Expt.  2 
t.t. ND 
tet3 
17.3 f 2.1 
ND 13.3 f 1.9 
9.8f  1.3  18.3 f 2.1  30.8 f 2.2  21.6 2 1.9 
6.2 5 1.1 15.2 f 1.7 0.6 f 0 . 1  1.6 f 0.1 
tet 1 5  ND 15.0 f 0.8 5.4 5 1.1 14.4 f 1.2 
None ND 1.3 & 0.1 0.6 f 0.1 0.6 f 0.1 0.8 f 0.1 0.9 f 0.1 
0.5 f 0 . 1  11.8 2 1.1 
" Aliquots of 2.1 O4 irradiated KK .35 B  cells (3500 rad] were added to 2. IO4 T  cells  in  the  presence or absence of 1 p g /  
ml of various t.t. preparations  (Expt. 1 )  in a final volume of 200 p l  RPMI-c. In the  case of B-fr. 4 . 2  B cells were used  (Expt. 
1). In Expt. 2, K K . 3 5  B cells were used and proliferative responses obtained with 1/1000 bacterial lysate dilution are 
presented. 
bAfter 2 days of incubation, 1 pCi["H]thymidine was added in each culture. Twenty-four hours later, incorporated 
radioactivity was  determined.  The  results  are  expressed in cpm f 1 SD for quadriplicate wells. Bold numbers indicate 
significant  T  cell proliferation. In the  absence of Ag. no T  cell proliferation was observed either in the  presence of K K . 3 5  
or 4.2 B cells. In Expt 1, background values for K K - 3 5  and 4.2 B cells  alone were 5.5 % 1.4  and 2.3 2 1.1. respectively. 





0 .0001 .001 .01 . 1  1 1 0  
pM antigen 
presented by B-fr- or C-fr-specific  B cell line. Aliquots of 2 .  lo4 KT-2 T 
Figure2.  Proliferative response of K T - 2  T cell clone to t.t. or B-fr 
cells were added to 2.10" irradiated (3500 rad) B-fr-specific  B  cells ( 4 . 2 ,  
various  concentrations of t.t. (open  symbol) or B-fr (closed symbol) in a 
square)  or C-fr-specific B cells (KK.35.  triangle) in the presence of 
thymidine was added to  each  culture.  Twenty-four hours later, incorpo- 
final volume of 200 pl of RPMI-c. After 2 days of incubation, 1 pCi ["HI 
quadriplicate wells. S D  were less  than 20%. 
rated radioactivity was  determined.  The  results  are  expressed in cpm for 
than KK. 35 B cells (Fig. 2).  These  observations  indicated 
that Ag presenting efficiency was greatly  enhanced upon 
recognition of Ag by B cell surface lg. 
Delineation of antigenic  peptides  using  proteolytic 
digestion  and  chemical  modifications of tetanus  toxin. 
It was observed that glutaraldehyde fixed B cells could 
present a preparation of  CNBr RCM4.t. to the five T cell 
clones but  not  the  intact  either native or reduced and 
alkylated  protein  [Table IV, data not  shown).  Therefore, 
the epitopes of these T cell clones were all located be- 
tween  methionine  residues. The effect of several enzy- 
matic or chemical modifications on the antigenicity of 
CNBr RCM-t.t. preparation  was  then evaluated. I t  was 
assumed that loss of antigenicity implies that  the hit 
amino acid residues are present in the T cell epitope. 
Alternatively, if the modification did not  affect  the T cell 
response these  residues  are  absent from the epitope. 
CNBr RCM-t.t. preparations  were  treated  with  trypsin, 
Lys-C endoproteinase, V8 protease at pH 4.0  in ammo- 
nium  acetate  buffer  and at pH 7.8 in phosphate  buffer, 
Asp-N endoproteinase,  chymotrypsin, and performic 
acid. 
T cell proliferation was  measured in response to var- 
ious concentrations of these CNBr RCM-t.t. preparations 
presented by glutaraldehyde-fixed B cells. This procedure 
was done to ensure  that  the  results would not be affected 
by the presence of some unmodified t.t. material in the 
various  preparations.  The comparison of the concentra- 
tion of the various CNBr RCM-t.t. preparations required 
to elicit 50% of the maximal proliferative response  rela- 
tively to the  untreated preparation allowed one to con- 
clude if lysine,  aspartic  acid,  glutamic acid and eventually 
tyrosine and/or tryptophane residues were present or 
absent in the antigenic peptides. This  set of experiments 
are presented in Table IV. Subsequently, the peptides 
which  fitted  to  these  conditions were sought  within the 
t.t.  sequence. 
The epitope of the KT-2 T cell clone contained at least 
one lysine residue and no  aspartic acid and glutamic acid 
residues (Table IV). The  t.t.  sequences 830-843  and  849- 
864 matched these conditions.  Therefore,  synthetic pep- 
tides corresponding to these two fragments were pro- 
duced and tested in a proliferation assay. The peptide 
830-843 induced KT-2 T cells to proliferate, whereas 
peptide 849-864 did not (Fig. 3a). Consequently, the  t.t. 
fragment 830-843 contains the epitope recognized by 
KT-2 T cells. The  amino acid sequence of KT-2 antigenic 
peptide is presented in Figure 3a. 
I t  was observed that KT-4 T cell proliferation could be 
induced by preparations of chym. RCM-t.t. presented by 
glutaraldehyde-fixed B cells (Table IV). This indicated 
that a fragment bearing KT-4 T cell epitope was pro- 
duced. The peptide which was  antigenic for KT-4 T cells 
was purified. A preparation of chym. RCM-C-fr was  sub- 
mitted to two steps of reverse phase high pressure liquid 
chromatography  (see Material and  Methods for proce- 
dure followed).  Due to the  uncertainty of the N-terminal 
residue, peptides corresponding  to  sequences 1272-1 284 
and 1273- 1284 with  either an aspartic acid or an aspar- 
agine residue in position 1272 were produced. These 
peptides proved to be equally stimulatory (Fig. 3b  and 
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TABLE IV 
K T - 2 ,   K T - 4 ,   K T - 3 0 ,   K T - 4 0 .  and K T - 4 2  T cell  proliferative  responses to various  chemically  modified t.  t. preparatfons 
Treatment of 
CNBr RCM-t.ta 
CNBr RCM4.t. (rglml] Required  to  Elicit 50% of Maximal 
T Cell Proliferative Responseb 




V8, pH 4.0 
V8. pH 7.8 
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Lys. Asp. Trp/Tyr 
ASD. Glu 
Lys, Asp. Glu 
Glu 
"CNBr RCM4.t. (-), trypsin-treated CNBr RCM-t.t. (Tryps.). Lys C  endoproteinase-treated CNBr RCM-t.t. (Lys-C). V8 
endoproteinase-treated CNBr RCM4.t. at  pH 4.0 (V8. pH 4.0). V8  endoproteinase-treated CNBr  RCM-t.t at pH 7.8 (V8, pH 
treated CNBr RCM4.t. (Perf.  acid)  were  prepared as described  in  Materials and Methods. 
7.8). Asp N endoproteinase-treated CNBr RCM4.t (Asp N), chymotrypsin-treated RCM-t.t. (Chym.). and performic acid 
t.t.  preparations.  After 2 days of incubation, 1 pCi [3H]thymidine  was added in  each  culture.  Twenty-four  hours  later, 
T  cells (2.  lo4] were added to 2. lo4 glutaraldehyde-fixed KK.35 B cells in  the  presence of various  concentrations of 
incorporated  radioactivity  was  determined.  The  results  represent the  concentrations of t.t.  preparations  in pg/ml required 
to elicit 50% of the  maximal  proliferative  response. 
corresponding T cell epitope. 
"'Present" and  "absent,"  respectively,  mean  that  the  indicated  amino acid residues are found and  are not found  in  the 
to t.t.  preparations  and  synthetic  peptides. a. 2.  lo4 irra- 
Figure 3. KT-2 and KT-4 T cell proliferative  response 
diated  B cells (3500 rad]  were  added  to 2.  lo4 KT-2 T cells 
t.t.. 0.1 puml peptide 830-843 or 0.1 pplml peptide 849- 
in  the  presence or absence of either 10 pplml CNBr  RCM- 
864 in  a  final volume of 200 ~ r l  RPMI-c. The t.t. sequence 
830-843 is presented  with  the  standard  three-letter code. 
KT-4 T  cells  in the presence or absence of either 40 p g /  
b. 2. lo4 irradiated B cells (3500 rad) were added  to 2.  lo4 
ml CNBr RCM4.t.. 40 pg/ml chymotrypsin-treated RCM- 
t.t.. 0.1 pg/ml peptide 1273-1284. 0.1 pg/ml peptide 
1274-1 284, 25 pg/ml peptide 1274-1 284. or 25 pg/ml 
The  t.t. sequence 1273- 1284 is presented with  the  stand- 
peptide 1275-1284 in a final volume of 200 pl RPMI-c. 
ard  three-letter code. After 2 days of incubation, 1 pCi I3H] 
thymidine  was  added  in  each  culture. At 24 h,  incorpo- 
rated radioactivity was determined. The results are ex- 
pressed  in cpm for  quadriplicate wells. SD were  less than 
20%. 
a .  
H-thymidine, cpm x 10 incorporated by K T 2  
1 0  20 3 0  4 0  
10 pglml CNBR RCM-t.t. 
0.1 pglml peptide 830-843 
0.1 pglml peptide 849-864 
Gln-Tyr- l le-Lys-Ala-Asn-Ser-Lys-Phe-l le-Gly-l le-Thr-Glu 
830  843 
b .  
H-thymidine, cpm x 10 Incorporated by KT-4 - 3 .  
10 2 0  30 4 0  
40 pglml CNBr RCM4.t. 
40 pglrnl chyrn. RCM-1.t. 
0.1 pg/ml peptide 1273-1284 
0.1 pgirnl peptide 1274-1284 
25 pg/ml peptlde 1274-1284 
25 pglrnl peptide 1275-1284 
Gly-Gln-l le-Gly-Asn-Asp-Pro-Asn-Arg-Asp-I le-Leu 
1273 1284 
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data not shown).  This  demonstrates that  the KT-4 T cell 
epitope is located within peptide 1273-1284 of t.t.  The 
amino acid sequence of this peptide is presented in Figure 
3b.  Shorter  synthetic  peptides were also produced. Pep- 
tide 1274-  1284  was 250-fold less  stimulatory than pep- 
tide 1273-  1284.  Half-maximal  response was triggered by 
20 ng/ml peptide 1273-1284 and by 5 &/ml peptide 
1274-1  284. Peptide 1275-  1284  was not at all  antigenic 
for KT-4 T cells (Fig. 3b). 
Determination of the MHC class 11 restriction ele- 
ments and alleles  utilized by the T cell clones KT-2, 
KT-4,  KT-30,  KT-40, and KT-42. T cells were stimulated 
to proliferate by using a limited number of t.t. pulsed and 
fixed B cells. Either  anti-DR, -DP, or -D9 mAb were added 
in  culture  to  determine  which of these  three MHC class I1 
elements  was used. Anti-DR  mAb strongly  inhibited (85 
to 94%)  the proliferation of the five T cell clones  tested. 
Anti-DP and anti-DQ mAb were  ineffective in inhibiting 
proliferation of the T cell clones  analyzed  (Table V). When 
the  number of B cells was increased (2. lo4 instead of 
500 to 5000), no inhibition  was observed with anti-DR 
mAb, ruling out the possibility that this mAb may be 
toxic for T cells (data not shown).  Thus, we concluded 
that DR Ag is the restriction  element used by these T cell 
clones. 
The clones were then tested for their ability to prolif- 
erate by using  different CNBr RCM4.t. pulsed DR homo- 
zygous B cell lines as APC. KT-4 and KT-42 T cell clones 
were stimulated  to  proliferate upon interaction  with CNBr 
RCM-t.t. pulsed COX and HAR and not with WT-20, WT- 
49,  and LG-14  DR3 homozygous B cell lines  (Table VI). 
KT-2, KT-30, and KT-40 T cell clones proliferative 
responses were induced by CNBr RCM-t.t. pulsed ATH 
and LC 38 DR5 homozygous B cell lines  (Table VI). The 
EDR DRI homozygous B cell line did not present CNBr 
RCm-t.t. peptides  to any of the T cell clones (Table VI]. 
The  observation that KT-4 and KT-42 T cells were not 
stimulated by Ag pulsed WT-20, WT-49, and LC- 14 cells 
suggested that DRa:DR3@III was  the restriction  element 
utilized by these two T cell clones. To test  this hypothesis, 
L cells transfected with the  genes coding for DR3, 
DRw52a. or DRw52b were used as APC (34).  TR-166 C2, 
TR-81.19, and TR-163 L cells, respectively, expressed 
40, 95, and  15% of HLA-DR Ag compared with KK.35 B 
cells as assessed by L.243 mAb binding assay  (data not 
shown). TR-81.19 L cells (DRw52a) pulsed with CNBr 
RCM-t.t. and glutaraldehyde fixed induced KT-4 and KT- 
42  T cell proliferative responses. Neither TR-166-C2 L 
cells (DR3) nor  TR-163 L cells (DRw52b) displayed this 
capacity (Table VII). Therefore, DRw52a is the restriction 
element utilized by  KT-4 and KT-42 T cell clones. 
DR5 allele is always  associated with DRw52b within 
the Caucasian population (41). In all  experimental con- 
ditions tested, KT-2, KT-3, or KT-40 T cells were not 
stimulated by  Ag-pulsed TR163 L cells (data not shown). 
Thus, although not formally proven, it is reasonable  to 
assume  that DR5 is the restriction  element utilized by 
KT-2, KT-30, and KT-40 T cell clones. 
Table VI11 summarizes  the  data obtained regarding the 
epitopes recognized and  the MHC class I1 molecules uti- 
lized  by the various T cell clones. 
DISCUSSION 
In the  present  study, t.t.-specific human T cell clones 
were characterized in terms of their Ag specificity and 
class I1 restriction  element utilized. Although all the re- 
striction  elements used were determined (Table VIII), the 
exact  antigenic  fragment recognized by the T cells was 
established  for only two clones (Table VIII). Although the 
number of T cell clones analyzed was  small, no immu- 
nodominant site was detected. In consequence, it is 
thought that other T cell epitopes could be detected 
through the  entire sequence of t.t. Another T cell clone 
was  shown to be specific for TT but not for native  t.t. 
This T cell clone could recognize clostridial proteins 
found in the crude preparations of TT which contain 
about 50% of other  bacterial  proteins (Dr. J. Cryz, Swiss 
Serum Institute, Bern, Switzerland, personnal commu- 
nication]. Alternatively, it may recognize an epitope 
created by formaldehyde treatment of t.t. Upon detoxifi- 
cation, some lysine residues are methylated and cross- 
linked with  tyrosine and  other lysine residues  (42). Pre- 
liminary  results  indicate that  this clone is not an isolated 
case.  it would mean that vaccination  with TT elicits a  T 
cell response  which is directed only in  part  against  the 
native form of t.t. 
Fusion  proteins  containing  t.t.  fragments were used to 
further define the location of T cell epitopes on t.t.  This 
technique  was readily applicable in  our  system  without 
any purification step  since some of the fusion  proteins 
displayed a  native structure.  Tet3  and  tetl5 fusion pro- 
teins were recognized by C-fr-specific Ab whereas reduc- 
tion and alkylation abrogated binding. Therefore,  with C- 
fr-specific B cells, lysate of lo6 bacteria was  sufficient  to 
trigger T cell proliferation,  whereas if fusion protein un- 
specific B cells were used, 10,000-fold more lysate would 
be required. The  latter dilution of bacteria  lysate (10" 
bacteria)  appeared toxic in the T cell proliferation assay. 
TABLE V 
Blocking of prolgeratiue  response of t.t.-spec$ic T cell clones by mAb directed  against  various MHC class I1 
molecules 
mAb" 
(3HiThymidine. cpm X Incorporatedb 
K T - 2   K T - 4   K T - 3 0  K T - 4 0   K T - 4 2  
None 8 . 9 5  1.1 15.2 f 2.0 10.4 C 0.5 19.2 f 0.8 56.0 C 2.7 
L.243 (anti-DR) 0.5 2 0.1 (94) 2.3 f 0.5 (85) 1.2 2 0.1 (88) 1.1 f 0.3  (94) 4.2 2 1.1 (93) 
Leu 10 (anti-DQ) 6.4 f 1 . 1  (28) 14.3 f 1.9 (6) 11.3 f 0.2 (-9) 15.0 + 2.4  (22) ND 
B7.21 (anti-DP) 8.3 f 1.3 (7) 15.8 f 2.2 (-4) 10.4 f 1 . 1  (0) 14.6 f 2.1 (24) ND 
KK.35 B cells were pulsed overnight with 0.25 pgml  t.t.  and  then glutaraldehyde fixed. Aliquots of 5 .  lo3  B cells (500 
in the  case of KT-42 T cells) were added to 2.  lo4 T  cells  in  the  presence or absence of 8 pg/ml mAb L.243 (anti-DR). mAb 
Leu 10 (anti-DQ). or mAb B 7.21 [anti-DP) in a final  volume of 200 p l  RPMI-c. 
radioactivity was determined. The results are expressed in cpm * 1 S D  for triplicate wells. Bold numbers Indicate *After 2 days of incubation, 1 pCi[3H]thymldine was added in each culture. Twenty-four hours later, incorporated 
significant inhibition of T cell proliferation. Percentage of inhibition relatively to control without mAb is indicated In 
parentheses. 
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TABLE VI 
Presentation of CNBr RCM-t.t.   peptides  to K T - 2 .   K T - 4 ,   K T - 3 0 ,   K T - 4 0 ,  and K T - 4 2  T cell  clones by various HLA-DR 
homozygous B cefl  lines 
I3HIThymidine. cpm X Incorporatedb 
R Cell LineU 
KT-2 KT-4 KT-30 KT-40 KT-42 - 
K K . 3 5 ( 3 . 5 )  85.9220.3  113.5f 1.3 18.9f 2.6 32.3f4.0  22.3t 0.8 
EDR(l . l )  
7.1 f 0.2 
2.0 f 0.1  2.4 f 0.3  1.9 f 0.1 
HAR (3.3) 
2.3 k 0.3 
2.3 f 0.7 127.7 f 7.9 1.7 f 0.3  1.7 f 0.6 20.4 t 0.8 
2.5 f 0.1  2.2 f 0.2 
2.1 f 0.1 
WT-20 (3.3) 
1.3 f 0.3 14.9 -C 0.5 
1.1 f 0.2 1 .o f 0.2 
1.2 f 0.1 
WT-49 (3.3) 0.6 f 0 1 .o f 0.2  0.3 f 0.1 
0.6 f 0.1  0.9 f 0.3  0.9 2 0.1 0.8 f 0.2 
LG- 14 (3.3) 
0.9 f 0.3 0.5 2 0.1 
9.7 & 0.8 
0.4 k 0.2 
7 . 2  f 0.3 6.9 f 0.1 
ATH (5.5) 
7.9 f 0.4 
77.1 f 5.3 1.7 f 0 
8.0 & 1.2  10.3 k 0.7 
12.5 f 2.9  18.5 f 4.6 
LC-38 (5.5) 81.4 2 1.4 2.3 f 0 16.8 f 0 
1.4 f 0.1 1.5 f 0.1 
33.0 f 3.2 
0.2 f 0.1  0.2 f 0.1 
1.9 f 0.1 2.7 f 0 
0.5 f 0.5  0.4 f 0.4 0.1 f 0 0.1 f 0.1 
cox (3.3) 1.4 * 0.1 108.5 f 2.0 0.9 f 0 
- 
B cells were pulsed overnight  with 40  rum1 CNBr RCM-t.t. and  then  washed  three  times. Aliquots of 2. I O 4  irradiated 
B  cells (3500 rad) were added to 2.1 O4 T  cells  in a final volume of 200 GI RPMI-c. 
'After 2 days of incubation, 1 &i[3H]thymidine was added in each culture. Twenty-four hours later, incorporated 
radioactivity was  determined.  The  results  are  expressed  in  cpm f 1 SD for quadriplicate wells. Bold numbers indicate 
significant  T cell proliferation. 
TABLE VI1 
Presentation ofCNBr RCM-t.t.  peptides to K T - 4  and K T - 4 2  T cell 
clones by K K . 3 5  B cells  and  various HLA-DR transfected L cells 
I3HJThymidine. cpm X 
APCa Incorporatedb 
KT-4 KT-42 
K K . 3 5  27.3 f 1.4 110.1 f 1.3 
TR-81-19  (DRw52a) 9.7 f 2.7 
0.2 f 0.1 
TR-I63 (DRw52b) 
16.6 5 5.6 
0.2 _t 0.1 0.2 f 0.1 
0.1 f 0.1 0.1 f 0.1 
TR- 166-C2  (DR3) 0.2 f 0.1 
- 
a K K . 3 5  B cells  and L cells  were pulsed overnight  with 100 Wgg/rnl CNBr 
RCM-t.t. and  then  glutaraldehyde fixed. Aliquots of 2.   lo4 B cells or L 
cells were added to 2.  lo4 T cells in a final volume of 200 pl RPMI-c. 
culture. Twenty-four hours later, incorporated  radioactivity  was  deter- 
bAfter 2 days of incubation, 1 pCi(3Hjthymidine was added in each 
mined.  The  results are expressed  in  cpm f 1 SD for quadriplicate wells. 
Bold numbers indicate  significant  T cell proliferation. KT-4 and KT-42 
T cell proliferation triggered by unpulsed APC was  less  than  0.5 X IO3 
cpm. 
TABLE VI11 
Summary of t . t .  fragments  recognized by the  various T cell  clones 
and  the  restriction  elements  utilized 
Cell Clone Shortest Defined t.t. Fragment Restriction 
















The use of specific endopeptidases to map  the epitope 
recognized  by T cell clone KT-2  could represent a general 
approach for delineating epitopes in  cases in which the 
protein is available  in fig quantities.  This novel and  sim- 
ple method has  the  advantage of limiting the  number of 
peptides to be  synthesized. For example, in the  case of 
this epitope only two peptides were made (Fragments 
830-843 and 849-864). In contrast, according to the 
method established by the group of Atassi (6), 10 overlap- 
ping peptides of 15  amino  acids had to be synthesized to 
cover the entire sequence 744-864 of t.t. The peptide 
830-843 contains one of the two sequence patterns 
which Rothbard and Taylor (43) recently described as  
being common to numerous T cell epitopes. The algo- 
rithm established by De Lisi and Berzofsky (44) also 
predicted that  fragment  830-843 might represent a T 
cell epitope. This peptide could assume an  a-helical struc- 
ture segregating hydrophobic and hydrophilic residues. 
On the  other  hand, epitope 1273-1284  does not contain 
any of the motifs described above. The presence of a 
proline residue  in the middle of the KT-4 epitope suggests 
the possibility that  this peptide does not display an 01- 
helical structure partitioning hydrophobic and hydro- 
philic residues.  This peptide might assume a P-turn struc- 
ture as proline and  asparagine  are two of the seven most 
frequent  residues  found in loops (45).  Furthermore, as- 
partic acid 1278  and arginine  1281 may be important for 
stabilizing the hairpin stucture through an ionic bond. A 
similar structure  was already suggested for another T 
cell epitope in  the mouse (1  1). 
The Ag specificities of three other clones were partially 
characterized and shown to be different. As KT-4,  KT-30 
was specific for C-fr but  was not stimulated by the  t.t. 
fragment  1273-  1284.  Therefore,  the epitopes recognized 
by these two clones are different.  The Ag specificity of 
clone KT-42 was assigned within fragment 604-742. 
However, we did not succeed in precisely mapping the 
KT-42 epitope even though all the peptides containing 
lysine, aspartic acid and glutamic acid residues  within 
fragment 604-742 were produced. One explanation is 
that asparagine or glutamine residues may have been 
deamidated during  t.t.  purification, suggesting that  en- 
zymatic cleavage with V8  protease  and/or Asp-N endo- 
proteinase may have occurred at these modified sites. 
The conversion of asparagine  and glutamine  residues  to 
the corresponding acid is a well known and common 
modification occuring in proteins (46). An example of 
deamidation was also observed in the natural peptide 
1272- 1284  in which an aspartic acid residue at position 
1272 was found by sequence analysis in place of an 
asparagine residue as determined by DNA sequence 
analysis  (data not  shown). 
Finally, KT-40 T cell clone recognized an epitope lo- 
cated in the t.t. fragment 2-602. Preliminary results 
indicated that  this T cell clone was specific for the light 
chain  (data not shown). 
The five T cell clones studied were DR-restricted. This 
observation was not surprising  since  several  reports  have 
indicated that DR antigen is the most frequently used 
restriction  element  (47,  48).  Furthermore, the five T cell 
clones  have  different  antigenic specificities. Although the 
number of T cell clones analyzed was  small. the obser- 
vations reported here would indicate the  absence of any 
dominant epitopes in the t.t. protein in  contrast to what 
observed in several  murine  systems (2.3,  7, 1  1)  and once 
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in  the  human system (5). 
Three of these clones are DR5-restricted although this 
was not formally proven. On the other hand, we have 
directly demonstrated that two t.t.-specific T cell clones 
utilize DRw52a molecules as  restriction  element by the 
use of murine L cells transfected  with HLA class I1 mol- 
ecules.  Furthermore, the epitope of KT-4 which is asso- 
ciated with DRw52a was precisely mapped within a pep- 
tide of 12  amino acid residues. In this  respect, Irl6 et al. 
(49) have  recently  shown that DR3, DRw52a, and 
DRw52b represent functional restriction elements for 
TT-specific T cell clones. However, they did not  define 
TT sequences recognized by these T cell clones. 
Tiercy et al. (41) have shown that  the allele DR3 is 
always  associated  with DRw52a or DRw52b in  the Cau- 
casian population. This would explain why out of five 
DR3 homozygous B cell lines,  three failed to  present CNBr 
RCM-t.t. peptides to KT-4 and KT-42 T cells. Typing 
showed that WT-49 B cell line is DR3, DRw52b (C.  Irlk, 
Transplantation Immunology Unit, Hbpital Cantonal 
Universitaire,  Geneva,  Switzerland,  personal  communi- 
cation).  Subsequently, we postulate that WT-20 and LG- 
14 B cell lines  also  express DRw52b. I t  is noteworthy to 
mention that T cell clones  which share  the  same  anti- 
genic specificity with KT-4 clone are found  in  other DR3 
and DRw6 individuals (P. Panina, A. Tan, S. Demotz, G. 
Corradin, and Lanzavecchia,  manuscript  in  preparation). 
These two haplotypes are associated  with DRw52a (41). 
The  sequence of the  genes coding for DR3, DRw52a, 
and DRw52b have  been  recently  published  (49). DRw52a 
and DRw52b differ in 11 amino acid residues. These 
differences  seem to be mainly located in the cleft of the 
HLA class I1 molecule which represents  the putative pep- 
tide binding  site (18). 
It is now conceivable to use KT-4 and KT-2 antigenic 
peptides as carrier molecule for B cell epitopes in DRw52a 
and DR5 positive and TT-primed individuals  in a manner 
similar to  that described recently by several authors  (2 1 - 
25).  The  use of peptide as carrier would in principle avoid 
the  manifestation of carrier specific suppression  encoun- 
tered  in  different  carrier systems when the  entire mole- 
cule is used (50-52). 
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